Are Louisiana Residents Eligible for Insulin Overpricing Compensation?

Home  /  Blog  /  Are Louisiana Residents Eligible for Insulin Overpricing Compensation?
Are Louisiana Residents Eligible for Insulin Overpricing Compensation?

  |   Apr 11, 2026  |  Class Action Lawsuit

Over the past several years, there have been major developments in landmark cases nationwide targeting various drug manufacturers and pharmacy benefit managers concerning unfair price increases for insulin products, but are Louisiana residents eligible for insulin overpricing compensation

If you believe you have overpaid for insulin, it’s vital to hire an insulin overpricing litigation lawyer as soon as possible to discuss your legal options. Confronting a large corporation like a drug manufacturer and/or pharmacy benefit manager is incredibly daunting, but an experienced attorney on your side can level the playing field and enable you to recover compensation for the damages you have suffered. 

Are Louisiana Residents Eligible for Insulin Overpricing Compensation?

Insulin is a necessary medication for anyone who has diabetes. This medication is relatively inexpensive to produce, but only a handful of companies are able to manufacture insulin products in the US due to the patents they hold. This has effectively created a monopoly, and recently, these companies have taken their unfair practices to new levels by dramatically increasing the prices of their insulin products. 

In 2023, the Louisiana Attorney General Jeff Landry filed a lawsuit against various drug manufacturers and pharmacy benefit managers over what he claims to be a fraudulent scheme intended to defraud those who rely on critical life-saving medication for no reason other than the enrichment of these businesses. 

In a March 2023 press conference, the Attorney General reported that diabetes is a public health crisis that is acutely felt in Louisiana, where, at the time, more than 505,000 state residents had been diagnosed with diabetes, and more than 1.2 million state residents were prediabetic, likely to become diabetic in the future. 

Insulin overpricing cases have developed in multiple districts throughout the US in recent years, targeting drug manufacturers like Eli Lily, Novo Nordisk, Inc., and Sanofi-Aventis, US, as well as pharmacy benefit managers like Optum Rx, CVS Caremark, and Express Scripts. 

These suits allege that pharmacy benefit managers received exorbitant rebates from these manufacturers in exchange for listing the manufacturers’ insulin products on patient pharmacy insurance plans. These manufacturers also have known histories of patent abuse, essentially enabling them to maintain a three-point monopoly on insulin products in the US and preventing other manufacturers from releasing biosimilar and more competitively priced insulin products. 

The result of these pharmacy benefit rebates was increased costs for insulin products, some of which reached exorbitant prices. Insulin is a crucial, lifesaving medication for anyone with diabetes. If they are forced to ration insulin doses due to high costs, they can suffer organ damage and various other severe adverse health effects. 

Claiming Compensation for Insulin Overpricing in Louisiana 

If you are wondering whether Louisiana residents are eligible for insulin overpricing compensation, it is vital to speak with an attorney who has proven experience handling these complex cases. Your attorney can review the details of your situation, assess whether you have suffered measurable damages because of the ongoing insulin price scheme, and then explain the steps you will need to take to recover compensation for your damages. 

Your attorney can review the pricing practices of the drug manufacturers and/or pharmacy benefit managers in question, calculate the damages you suffered, and assist you with building a case. Success with this type of case requires proving that the defendant’s practices resulted in financial losses. You may need evidence that you do not know how to obtain on your own, and your attorney can also support your case by referencing ongoing insulin overpricing cases in the US. 

The insulin overpricing schemes that have been uncovered throughout the US have led to multi-district litigation that is still taking form. The attorneys at Ron Austin Law have extensive experience representing clients in these difficult cases, and we can help you understand your legal options if you and your family have been adversely affected by any insulin overpricing scheme in Louisiana. Reach out to our firm as soon as possible to learn how we can help.

FAQs

Is Insulin Covered by the Inflation Reduction Act? 

Yes, insulin is covered by the Inflation Reduction Act. Under this law, the out-of-pocket costs for insulin are capped at $35 per monthly prescription for those covered by a Medicare Part D plan, effective January 1, 2023. A similar cap was applied to Part D plans on July 1, 2023.

Why Is Insulin Overpriced?

Insulin is overpriced primarily because three main companies control the insulin supply of the United States: Eli Lily, Novo Nordisk, Inc., and Sanofi-Aventis US. These companies arranged deals with pharmacy benefit managers, who received rebates in exchange for listing these companies’ insulin products in their patient pharmacy insurance plans. The manufacturers then raised their prices to account for these massive rebates, effectively passing the cost to the patient.

Can I Sue for Overpriced Insulin in Louisiana? 

Yes, it is possible to sue for overpriced insulin in Louisiana. You should speak with a Louisiana insulin overpricing litigation attorney as soon as possible to discuss your case; they can explain whether you have a case. You will need to prove that the manufacturer’s pricing practices resulted in economic losses and/or other harm. 

What Damages Can I Claim in an Insulin Overpricing Case? 

The damages you could claim in an insulin overpricing case may include medical expenses, lost wages, other out-of-pocket expenses, and pain and suffering. A skilled Louisiana insulin overpricing litigation attorney can review the details of your situation, determine whether an insulin manufacturer’s practices resulted in harm, and, if so, help you build a civil claim. 

Why Should I Hire an Insulin Overpricing Litigation Lawyer? 

You should hire an insulin overpricing litigation lawyer because confronting any major pharmaceutical company is inherently difficult, and hiring an experienced attorney levels the playing field between you and the defendant. Your attorney can help you prove liability for the damages you suffered, gather evidence that shows the defendant’s pricing practices were unfair and/or fraudulent, and assist you with recovering compensation for your damages.

Louisiana Insulin Overpricing Litigation Law Firm

If you are wondering whether Louisiana residents are eligible for insulin overpricing compensation, it’s crucial to speak with an attorney who has proven experience handling these cases. Ron Austin Law excels at complex litigation, including cases spanning multiple districts. We can help you understand your legal options for insulin overpricing, so contact us today to schedule a free consultation with a Louisiana insulin overpricing litigation attorney.

Louisiana Image

In the heart of New Orleans

Proven Billion-Dollar Results. Justice for Louisiana Families.

Contact Us Today

Fields Marked With An ”*” Are Required

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
*

Westbank Office

400 Manhattan Boulevard
Harvey, LA 70058 Get Directions

Contact

Call Us

504-227-8100

© 2026 Ron Austin Law• All Rights Reserved. Disclaimer | Site Map | Privacy Policy. Digital Marketing By: rizeup media logo